titlesubmit dateissue date
Now showing items 1-4 of 4
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
Genome-wide analysis of differential transcriptional and epigenetic variability across human immune cell types
Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer.
Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.